NVS logo

NOVARTIS AG-SPONSORED ADR

NVSNYSE
Earnings Feb 3 Β· PostUS Equity
β€”β€”
Quote unavailable
πŸ””
Track NVS
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
β€”
πŸ“ˆRevenue Growth (YoY)
2.3%
Slowing
πŸ“ŠGross Margin
75.2%
High
πŸ’΅FCF Margin
24.4%
Strong
βš–οΈP/S Ratio
4.8x
Fair
Otter Score
76
Strong
No chart data available for NVS.

Trading Snapshot

Day Range
β€”
52-Week Range
$99.45 – $137.00
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
2.03B
Next Earnings
2027-02-03

Fundamentals Snapshot

Annual Revenue
$54.81B
Last Q Revenue
$15.03B
P/E Ratio
27.6
P/S Ratio
4.8x
EPS (TTM)
$5.23
Dividend Yield
3.28%
Dilution (1yr)
βˆ’3.7%
NVS logo

NOVARTIS AG-SPONSORED ADR

NVS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$54.8Bβ–² +6.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
75.0%β–Ό βˆ’0.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$17.1Bβ–² +17.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$17.7Bβ–² +28.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.93Bβ–Ό βˆ’3.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$25.7Bβ–Ό βˆ’$5.9B YoY
StockOtter Β· stockotter.space

About NOVARTIS AG-SPONSORED ADR

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
76/100
Analyst data unavailable.

Latest News & Updates

News unavailable.